| 1000 Genomes Project |
cohort |
114 |
54 |
1000 Genomes, 1000 Genomes European, 1000 Genomes European sample, 1000 Genomes Phase 3, 1000 Genomes Phase 3 v5, 1000 Genomes Phase3, 1000 Genomes Project, 1000 Genomes Project Consortium, 1000 Genomes Project Consortium 2010, 1000 Genomes Project phase 3, 1000 Genomes Project pilot 1, 1000 Genomes data, 1000 Genomes data set, 1000 Genomes individuals, 1000 Genomes panel, 1000 Genomes phase 3 reference panels, 1000 Genomes reference, 1000 Genomics Project, 1000 genomes phase1, 1000 genomes phase3, 1000 genomes project, 1000 genomes project pilot, 1000G, 1000G Phase 3, 1000G Phase 3 v5, 1000G reference, 1000GP, 1000Genomes, 1KG, 1KG Project, 1KG phase 3 data, 1KGP, African 1000 Genomes Project phase 3, EUR, EUR reference set, European reference panel, Europeans from the 1000 Genomes, June 2010 release, Phase 3, Phase 3 v5a, Phase 3 version 5, Sanger Institute, The 1000 Genomes Project, The 1000 Genomes Project Consortium, phase 3, phase 3 of the 1000 genomes project |
| 16p11.2 CNV |
variant |
3 |
3 |
16p11.2, 16p11.2 copy number variation |
| 16p11.2 deletion |
variant |
6 |
5 |
16p11.2 CNV deletion, 16p11.2 del, 16p11.2 deletion, 16p11.2 deletions, 220 kb deletion of chromosome 16p11.2, chromosome 16p11.2 deletion, previously identified deletion on chromosome 16p11.2, reciprocal deletion of 16p11.2 |
| 16p11.2 duplication |
variant |
5 |
3 |
16p11.2 CNV duplication, 16p11.2 dup, 16p11.2 duplication, 16p11.2 duplications, chromosome 16p11.2 duplication, duplications of chr16p11.2, reciprocal duplication of 16p11.2 |
| 1958 British Birth Cohort |
cohort |
5 |
3 |
1958 Birth Cohort |
| 1KGP |
cohort |
3 |
1 |
1000 Genomes Project |
| 1q21.1 duplication |
variant |
3 |
2 |
1q21.1 CNV duplication, 1q21.1 dup, duplication at 1q21.1 |
| 2000 census |
cohort |
2 |
1 |
|
| 22q11.2 deletion |
variant |
5 |
2 |
22q11-13 deletion, 22q11.2 deletion, 22q11.2 deletion syndrome, 3Mb deletion at chromosome 22q11.21, DiGeorge syndrome deletion, chr22q11.21 deletion |
| 23andMe |
cohort |
20 |
14 |
23andMe, 23andMe cohort, 23andMe replication, 23andMe research participants, 23andMe sample, 23andMe, Inc. |
| 23andMe, Inc. |
cohort |
2 |
— |
23andMe |
| 2-AG |
drug |
7 |
7 |
2-Arachidonoylglycerol, 2-arachidonoylglycerol, 2-arachidonylglycerol, 2‑AG, 2‑arachidonoylglycerol, endogenous 2-AG |
| 2-mercaptoethanol |
drug |
6 |
3 |
|
| 2-year-old children |
cohort |
3 |
2 |
2 year olds, 2-year, 2-year-old children, age 2 |
| 3-hydroxycotinine |
drug |
5 |
4 |
3-HC, 3-hydroxycotinine, 3HC |
| 5-HT7 receptor |
drug |
2 |
2 |
5-HT7 |
| 5-HTTLPR |
variant |
18 |
5 |
5-HT transporter gene promoter length polymorphism, 5-HTT-linked polymorphic region, 5-HTTLPR, 5-HTTLPR genotype, 5-HTTLPR l allele, 5-HTTLPR long variant, 5-HTTLPR polymorphism, 5-HTTLPR s, 5-HTTLPR s allele, 5-HTTLPR short variant, L allele, LL, S, S allele, SL, SLC6A4 short allele, functional polymorphism near the serotonin transporter, l allele, l/l, l/l genotype, l/s genotype, long allele, long allele of the 5-HTT promoter polymorphism, long variant, s allele, s allele of the 5-HTTLPR, s/l, s/s, s/s genotype, serotonin transporter gene promoter, serotonin transporter genotype, serotonin transporter linked polymorphic region, serotonin transporter linked polymorphic repeat, serotonin transporter promoter polymorphism, serotonin-transporter-linked polymorphic region, short allele, short allele of 5HTTLPR, short allele of the 5-HTT promoter polymorphism, short promoter allele of 5HTTLPR, short variant |
| 5HTTLPR |
variant |
7 |
7 |
5-HTTLPR, 5HTT linked polymorphic region, 5HTTLPR, 5HTTLPR genotype, serotonin transporter linked polymorphic region, serotonin transporter promoter polymorphism, serotonin transporter promoter variant, serotonin transporter-linked polymorphic region, serotonin-transporter-linked polymorphic region, short allele of 5HTTLPR |
| 6-FAM |
drug |
3 |
1 |
carboxylfluorescein |
| 6-hydroxydopamine |
drug |
2 |
1 |
6-OHDA |
